Known targets — ChEMBL curated mechanism
SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5
The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.36 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | GRM8 | O00222 | 1/20 | 0.36 |
| ▸ | GRM6 | O15303 | 1/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.36 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aspartic Acid SCHEMBL20454596 | 1.00 | SLC22A6 (0.38) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL10799232 | 0.97 | SLC22A6 (0.39) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL120391 | 0.97 | SLC22A6 (0.39) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL5160188 | 0.95 | SLC22A6 (0.38) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL5195845 | 0.95 | SLC22A6 (0.38) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL3866867 | 0.95 | TDP1 (0.42) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL3976768 | 0.95 | SLC22A6 (0.38) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL2828201 | 0.95 | SLC22A6 (0.38) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL17350094 | 0.95 | SLC22A6 (0.38) | SLC22A6GABRR1CA4LMNATDP1 | |
| Aspartic Acid SCHEMBL17747944 | 0.95 | SLC22A6 (0.38) | SLC22A6GABRR1CA4LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12359164-B2 | Process for producing cell culture media | MERCK PATENT GMBH (DE) | 2025-07-15 | — | — | US | claimed |
| CN-114373870-B | Method for improving electron transmission efficiency of tin dioxide-lead halide perovskite interface | 中国科学院金属研究所 | 2025-02-25 | — | — | CN | claimed |
| US-20210207079-A1 | PROCESS FOR PRODUCING CELL CULTURE MEDIA | MERCK PATENT GMBH (DE) | 2021-07-08 | — | — | US | claimed |
| CN-111517970-A | Preparation method of L-aspartic acid sodium salt monohydrate | 安徽安力肽生物科技有限公司 | 2020-08-11 | — | — | CN | claimed |
| EP-3331986-B1 | PROCESS FOR PRODUCING CELL CULTURE MEDIA | MERCK PATENT GMBH (DE) | 2020-07-01 | — | — | EP | claimed |
| EP-2889369-B1 | YEAST CULTURE MEDIUM | UNIV YAMAGUCHI (JP) | 2020-03-25 | — | — | EP | claimed |
| US-20180223250-A1 | PROCESS FOR PRODUCING CELL CULTURE MEDIA | MERCK PATENT GMBH (DE) | 2018-08-09 | — | — | US | claimed |
| EP-3331986-A1 | PROCESS FOR PRODUCING CELL CULTURE MEDIA | Merck Patent GmbH (DE) | 2018-06-13 | — | — | EP | claimed |
| WO-2017020986-A1 | PROCESS FOR PRODUCING CELL CULTURE MEDIA | MERCK PATENT GMBH (DE) | 2017-02-09 | — | — | WO | claimed |
| JP-2010529198-A | — | — | 2010-08-26 | — | — | JP | claimed |
| US-20100209532-A1 | TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS | OPK BIOTECH LLC (US) | 2010-08-19 | — | — | US | claimed |
| EP-2170371-A1 | TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS | OPK Biotech LLC (US) | 2010-04-07 | — | — | EP | claimed |
| WO-2008156699-A1 | TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS | BIOPURE CORPORATION (US) | 2008-12-24 | — | — | WO | claimed |
| US-4035513-A | COSMETICS | SHISEIDO CO., LTD. (JA) | 1977-07-12 | — | — | US | claimed |
| EP-4744509-A1 | TASTE COMPOSITION FOR ENHANCING SALTY TASTE AND SALT-REDUCED SEASONING AND SALT-REDUCED FOODS OR BEVERAGES PRODUCED USING THE SAME | The University of Tokyo (JP) | 2026-05-20 | — | — | EP | disclosed |
| US-20250325591-A1 | THERAPY FOR HEPATIC DISORDERS USING ADIPOSE-DERIVED MESENCHYMAL STEM CELL LINE | UNIV KEIO (JP) | 2025-10-23 | — | — | US | disclosed |
| US-12383476-B2 | W/O/W emulsion composition | SHISEIDO COMPANY, LTD. (JP) | 2025-08-12 | — | — | US | disclosed |
| EP-0152275-A2 | Production of amino acids via bioconversion | THE NUTRASWEET COMPANY (a Delaware corporation) (US) | 1985-08-21 | — | — | EP | disclosed |
| US-4400287-A | SODIUM ACETATE TRIHYDRATE AND A NUCLEATING AGENT OF ANHYDROUS SODIUM ACETATE AND A SODIUM COMPOUND; SUPPORTS | MITSUBISHI DENKI KABUSHIKI KAISHA (JP) | 1983-08-23 | — | — | US | disclosed |
| US-4035513-A | COSMETICS | SHISEIDO CO., LTD. (JA) | 1977-07-12 | — | — | US | disclosed |